Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Musculoskeletal | Rheumatology | Family Medicine
Osteoporosis Clinical Trials
A listing of Osteoporosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Call for Information (Investigational Site 1032) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Birmingham : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Huntsville : Call for Information (Investigational Site 1020) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Arizona
Peoria : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Phoenix : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Scottsdale : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tucson : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Arkansas
Tucson : Call for Information (Investigational Site 1019) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
California
Anaheim : Anaheim Clinical Trials (ACT)
Are you concerned about Osteoporosis?
Walnut Creek : Diablo Clinical Research
Could you have thinning bones or osteoporosis?
Walnut Creek : Diablo Clinical Research
Do You Have Osteoporosis?
View More »
Anaheim : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
Concord : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Downey : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Fresno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Greenbrae : Call for Information (Investigational Site 1001) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Greenbrae : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hemet : Call for Information (Investigational Site 1009) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Laguna Hills : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Laguna Hills : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lancaster : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Los Angeles : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Murrieta : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Roseville : Call for Information (Investigational Site 1021) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Sacramento : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
San Diego : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
San Francisco : UCSF Imaging Center
Assessment of Bone Micro-Architecture Using HR-pQCT
San Luis Obispo : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Santa Monica : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Simi Valley : Call for Information (Investigational Site 1007) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
South Lake Tahoe : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tustin : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Valley Village : Call for Information (Investigational Site 1033) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Victorville : Call for Information (Investigational Site 1027) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Walnut Creek : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Walnut Creek : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Colorado
Denver : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Lakewood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Lakewood : Call for Information (Investigational Site 1043) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Lakewood : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lakewood : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
View More »
Lakewood : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lakewood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Longmont : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Connecticut
Middlebury : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
New Britain : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Florida
Fort Myers : Clinical Physiology Associates
Osteoporosis in Postmenopausal Women
West Palm Beach : Metabolic Research Institute, Inc.
Do you have Osteoporosis?
West Palm Beach : Comprehensive Clinical Trials
Osteoporosis Study
View More »
Boca Raton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Fort Lauderdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Fort Lauderdale : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Leesburg : Call for Information (Investigational Site 1018) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Leesburg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Miami : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
Miami : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
New Port Richey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Palm Harbor : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Stuart : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tampa : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Trinity : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
West Palm Beach : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Georgia
Atlanta : Radiant Research - Atlanta Updated
Osteoporosis
View More »
Atlanta : Call for Information (Investigational Site 1023) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Gainesville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Gainesville : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Gainesville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Gainesville : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Gainesville : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Gainesville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hawaii
Honolulu : Call for Information (Investigational Site 1045) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Idaho
Coeur d'Alene : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Meridian : Call for Information (Investigational Site 1038) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Illinois
Indiana
Evansville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Greenwood : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Indianapolis : Call for Information (Investigational Site 0002)
A Study of Odanacatib When Administered to Adolescents Treated With Glucocorticoids (MK-0822-066)
Indianapolis : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Kansas
Louisiana
New Orleans : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Shreveport : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Maryland
Annapolis : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Baltimore : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bethesda : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Bethesda : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bethesda : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
View More »
Bethesda : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Bethesda : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Elkridge : Call for Information (Investigational Site 1004) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Greenbelt : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Hagerstown : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Massachusetts
Boston : Massachusetts General Hospital
Testosterone and Alendronate in Hypogonadal Men
Boston : Massachusetts General Hospital
The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
Michigan
Detroit : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Detroit : Call for Information (Investigational Site 1024) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Detroit : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Detroit : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
View More »
Detroit : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Minnesota
Missouri
St. Louis : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
St. Louis : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nebraska
New Jersey
Berlin : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Berlin : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
Clifton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Englewood : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Mount Laurel : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
New Mexico
New York
Garden City : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Great Neck : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Mineola : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
New York : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Syracuse : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
West Haverstraw : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
North Carolina
Charlotte : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Durham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Durham : Call for Information (Investigational Site 1013) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Gastonia : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Greensboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Greenville : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
North Dakota
Ohio
Maumee : Call for Information (Investigational Site 1006) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Mayfield Village : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Pennsylvania
Philadelphia : Clinical Research of Philadelphia, LLC Updated
Are you a woman who has taken medication for Osteoporosis?
View More »
Bala Cynwyd : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Duncansville : Research Site
Effects of Denosumab on the Pharmacokinetics of Etanercept
Duncansville : Call for Information (Investigational Site 1029) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Duncansville : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Duncansville : Novartis Investigative Site
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density
Duncansville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Lancaster : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Philadelphia : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Pittsburgh : University of Pittsburgh, Osteoporosis Prevention & Treatment Center
Fracture (FX) Improvement With Teriparatide: FiX-IT Study
Pittsburgh : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Pittsburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Wyomissing : Call for Information (Investigational Site 1005) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Wyomissing : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tennessee
Nashville : Clinical Research Associates, Inc.
Osteoporosis Study for Women
View More »
Knoxville : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Texas
Dallas : Metroplex Clinical Research Center
Do You Have Rheumatoid Arthritis? Osteoporosis or Osteopenia? Research Study 20101324
Dallas : North Texas and Endocrine Center
Osteoporosis
Dallas : North Texas and Endocrine Center
Patients with severe postmenopausal osteoporosis: Comparative effects on vertebral fractures
View More »
Dallas : Research Site
Effects of Denosumab on the Pharmacokinetics of Etanercept
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Denton : Call for Information (Investigational Site 1052) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Denton : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Houston : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Virginia
Richmond : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Richmond : Call for Information (Investigational Site 1062) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Richmond : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Salem : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Virginia Beach : Call for Information (Investigational Site 1028) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Washington
Seattle : Call for Information (Investigational Site 1016) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
West Virginia
Clarksburg : Call for Information (Investigational Site 1011) Updated
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Wisconsin
Madison : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Argentina
Australia
Box Hill : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Darlinghurst : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Footscray : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Geelong : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Geelong : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
View More »
Geelong : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Heidelberg West : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Heidelberg West : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Herston : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Herston : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Keswick : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kogarah : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Maroubra : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Parkville : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Parkville : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Randwick : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Ringwood East : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
St Leonards : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Wahroonga : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Westmead : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Westmead : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Austria
Graz : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Graz : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Graz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hohenems : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Klagenfurt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
View More »
Landeck : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Leibnitz : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Linz : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Linz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Salzburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Salzburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Sankt Stefan : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Vienna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Voecklabruck : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Voitsberg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Wien : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Wien : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Belgium
Aalst : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Aalst : O.L. Vrouwziekenhuis
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Aarschot : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Alsemberg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Baisy-Thy : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
View More »
Blankenberge : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bornem : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Brain-Le-Comte : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Brugge : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Brussels : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Bruxelles : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bruxelles : CHIREC parc Leopold
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Bruxelles : ULB Hopital Erasme
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Bruxelles : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bruxelles : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Chênée : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Diepenbeek : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Eisden Maasmechelen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Genk : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Genk : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Genk : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Genk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Gent : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Gent : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Gent : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Gent : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Gent : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Gilly : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Gribomont : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Grimbergen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Haine Saint Paul : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Halen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Ham : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Ham-Sur-Heure : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Harelbeke : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hasselt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heusden : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heusy : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hoeilaart : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Knokke-Heist : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Kortrijk : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Kraainem : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Laken : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Landen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Leuven : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Leuven : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Leuven : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Leuven : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Leuven : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Leuven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Liège : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Liège : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Liege : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Liege : CHC St. Joseph
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Liege 1 : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Liege 1 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lummen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Marchovelette : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Merksem : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Merksem : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Mons : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Mont-Godinne : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Mont-sur-Marchienne : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Mouscron : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Natoye : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Paal-Beringen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Retie : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Seraing : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Steenokkerzeel : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Stoumont : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Thuilles : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Tongeren : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Vilvoorde : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Vlijtingen-Riemst : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Wetteren : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Yvoir : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Yvoir : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Brazil
Bulgaria
Plovdiv : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Sofia : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Canada
Barrie : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brampton : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brantford : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Burlington : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Calgary : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
View More »
Calgary : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Calgary : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Edmonton : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Halifax : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Halifax : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Halifax : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hamilton : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kelowna : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Kelowna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Kitchener : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Laval : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
London : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Montreal : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Montreal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Montreal : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Montreal : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Montreal : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Montreal : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Montreal : Mcgill University Health center
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
Oakville : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Oakville : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ottawa : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Ottawa : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Quebec : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Quebec : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Quebec : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Quebec : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Sainte-Foy : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Sainte-Foy : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Saskatoon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Sherbrooke : Centre hospitalier universitaire de Sherbrooke
Strategies to Treat Osteoporosis Following a Fragility Fracture
St. John : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
St. Johns : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Toronto : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Toronto : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Toronto : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Toronto : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Toronto : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Toronto : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Trois-Rivieres : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Trois-Rivieres : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Vancouver : Novartis Investigative Site
1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Vancouver : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Vancouver : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Vancouver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Vancouver : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vancouver : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Vancouver : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Vancouver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Victoria : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Victoria : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Westmout : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Winnipeg : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Winnipeg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Colombia
Barranquilla : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Bogota : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bogota : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Medellin : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Medellin : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Croatia
Osijek : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Rijeka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Sisak : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Zagreb : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Czech Republic
Benesov : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brno : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brno : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Brno : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Brno : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Ceske Budejovice : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Ceske Budejovice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ceske Budejovice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Havlickuv Brod : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Havlickuv Brod : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Hradec Kralove : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Jindrichuv Hradec : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Karlovy Vary : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Klatovy : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Klatovy : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Klatovy : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Klatovy : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Kromeriz : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Kutna Hora : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Olomouc : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Ostrava : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Ostrava-Trebovice : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Ostrava-Trebovice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ostrava-Trebovice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Pardubice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Pardubice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Pardubice :
Twenty Four Month Extension Study of BA058-05-003
Plzen : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Plzen : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Plzen : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Prague : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Prague : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Praha 11 : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Praha 11 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Praha 2 : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Praha 2 : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Praha 2 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Praha 2 : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Praha 3 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Praha 3 : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Praha 4 : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Praha 4 - Nusle : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Praha 6 : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Trutnov : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Uherske Hradiste : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Uherske Hradiste : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Usti nad Labem : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Vsetin : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zlin : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Zlin : Osteocentrum Zlin
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zlin : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zlin : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Denmark
Ã…rhus C : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ã…rhus C : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Aalborg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Aalborg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Aalborg :
Twenty Four Month Extension Study of BA058-05-003
View More »
Aarhus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Aarhus C : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Ballerup : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ballerup : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Ballerup :
Twenty Four Month Extension Study of BA058-05-003
Glostrup : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Glostrup : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hvidovre : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Hvidovre : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Køge : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Odense : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Odense : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Odense : Department of Endocrinology
Study of Male Osteoporosis and Aging
Odense : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Vejie :
Twenty Four Month Extension Study of BA058-05-003
Vejle : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vejle : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Viborg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Estonia
Pärnu : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tallinn : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tallinn : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tallinn :
Twenty Four Month Extension Study of BA058-05-003
Tartu : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Tartu : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Finland
Helsinki : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Jyväskylä : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Kuopio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Kuopio : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Oulu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
View More »
Turku : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
France
Angers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Caen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Cahors Cedex : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
La Crau : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
La Roche Sur Yon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
View More »
Lille cedex : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lyon : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Lyon : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lyon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Orléans Cedex : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Orleans : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Orleans : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Paris : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Paris : Cochin hospital
Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention
Saint Priest en Jarez : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Saint-Etienne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Saint-Etienne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Toulouse : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Toulouse : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Toulouse Cedex 9 : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Vandoeuvre les Nancy : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Villeurbanne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Germany
Aachen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Augsburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bad Reichenhall : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bammental : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Bautzen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
View More »
Berlin : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Berlin : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Berlin (Hellersdorf) : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cottbus : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Düsseldorf : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Dresden : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Dresden : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Dresden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Erfurt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Essen : Department of Internal Medicine III, Alfried Krupp Krankenhaus Essen Steele
Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
Frankfurt : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Frankfurt : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Frankfurt : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Freiburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Freiburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Freudenstadt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Friedrichroda : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Göttingen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Hamburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hamburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hannover : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hannover : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hattingen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heinsberg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heinsberg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hettstedt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Hildesheim : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Immenstadt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Koblenz : Katholische Klinikum Marienhof
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Lahnstein : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Leipzig : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Leipzig : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Leipzig : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Leverkusen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Mönchengladbach-Rheydt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Müllheim : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
München : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Magdeburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Magdeburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Mainz : UNIVERSITÄTSMEDIZIN der Johannes-Gutenberg Universität Mainz
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Marburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Marburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Marburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Muenchen : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nürnbrecht : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Neustadt : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Nienburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Osnabrück : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Potsdam : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Regensburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Saarbrücken : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Stockach : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Ulm : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Völklingen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Würzburg : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Würzburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Wadgassen : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Wittstock : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Zerbst : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Greece
Alexandroupoli : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Athens : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Athens : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Athens : Iaso Hospital of Athens, Center of Endocrinology and Bone Metabolism
Osteoporosis Screening Trial
Athens : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Athens : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Chaidari, Athens : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Chania, Crete : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heraklion : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Heraklion : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Heraklion, Crete : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Kifissia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Kifissia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Larissa : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Larissa : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Levadia : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Maroussi, Athens : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Patra : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Patra : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Patras : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Thessaloniki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Thessaloniki : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Thessaloniki : Research Site
Observational Study of Prolia® in Postmenopausal Women With Osteoporosis
Thessaloniki : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Thessaloniki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Hong Kong
Hong Kong : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hong Kong :
Twenty Four Month Extension Study of BA058-05-003
New Territories : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Hungary
Baja : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bekescsaba : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bekescsaba : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Budapest : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Budapest : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Budapest : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Budapest : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Debrecen : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Debrecen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Eger : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Gyor : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Gyor : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Heviz : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kaposvar : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Kiskunhalas : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nyiregyhaza : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Szeged : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Szeged : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Szeged : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Veszprem : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Zalaegerszeg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Zalaegerszeg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
India
Ahmedabad : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Aurangabad : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bangalore : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Chennai : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Jaipur : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Ludhiana : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Madurai : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Mumbai : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Nashik : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Pune : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vellore : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ireland
Italy
Arenzano GE : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cagliari : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Firenze : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Firenze : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Firenze : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Milan : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Milano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Nervi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Novara : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Padova : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Pisa : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Roma : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Rome : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Rome : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Siena : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Torino : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Torino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Valeggio Sul Mincio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Verona : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Japan
Akashi-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Anjyo-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Atugi-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bungo-Ono :
Study of AK156 in Primary Osteoporosis Patients
Bungoono-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Chiba :
Study of AK156 in Primary Osteoporosis Patients
Chiisagata-gun : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Chitose-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fujimi-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fujinomiya-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fukui-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fukuoka :
Clinical Study of AK159 in Healthy Postmenopausal Women
Fukuoka :
Study of AK156 in Primary Osteoporosis Patients
Fukuoka-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fukutsu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Hachioji-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Hiroshima-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Inami-cho :
Study of AK156 in Primary Osteoporosis Patients
Ishikari-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kagoshima :
Study of AK156 in Primary Osteoporosis Patients
Kako-gun : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kikugawa-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kikukawa :
Study of AK156 in Primary Osteoporosis Patients
Kirishima-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kitakyushu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kiyose-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kofu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kumamoto :
Study of AK156 in Primary Osteoporosis Patients
Kumamoto-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kure :
Study of AK156 in Primary Osteoporosis Patients
Kurume-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Many Locations :
Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Many Locations :
Wellnara Post-marketing Surveillance in Japan
Matsue-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Matsumoto :
Study of AK156 in Primary Osteoporosis Patients
Matsumoto-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Minamikyusyu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Minato-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Miyazaki :
Study of AK156 in Primary Osteoporosis Patients
Morioka :
Study of AK156 in Primary Osteoporosis Patients
Morioka-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Osaka-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Ota-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Oyama :
Study of AK156 in Primary Osteoporosis Patients
Sagamihara-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Saga-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Sapporo :
Study of AK156 in Primary Osteoporosis Patients
Sendai :
Study of AK156 in Primary Osteoporosis Patients
Sendai-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Setagaya :
Study of AK156 in Primary Osteoporosis Patients
Setagaya-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Shinagawa :
Study of AK156 in Primary Osteoporosis Patients
Shinagawa-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Suginami-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Sunagawa-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Takamatsu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Takatsuki-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tokorozawa :
Study of AK156 in Primary Osteoporosis Patients
Tokushima-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tonami :
Study of AK156 in Primary Osteoporosis Patients
Toride-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Toshima-ku : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Tosu :
Study of AK156 in Primary Osteoporosis Patients
Ueda-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Urayasu-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Yokohama :
Study of AK156 in Primary Osteoporosis Patients
Yokohama-shi : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Korea, Republic of
Seoul : Chung-ang university hospital
Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis
Seoul : The Catholic University of Korea Seoul St. Mary's Hospital
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Suwon : Ajou University Hospital
Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women
Latvia
Jelgava : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Liepaja : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Liepaja : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Riga : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Riga : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Riga : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lithuania
Kaunas : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Klaipeda : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vilnius : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Vilnius : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Malaysia
Kuala Lumpur : Hospital of UKM, National University of Malaysia
Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women
Mexico
Ciudad Obregon : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Distrito Federal : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Leon : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Mexicali : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Mexicalli : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Mexico : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Mexico : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Monterrey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Monterrey : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Querétaro : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Netherlands
Leiden : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Rotterdam : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Venlo : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
New Zealand
Christchurch : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Christchurch : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Christchurch : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Grafton, Auckland : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Takapuna, North Shore City : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Tauranga : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Norway
Elverum : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Oslo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Oslo : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Stavanger : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Poland
Bialystok : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bialystok : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Bialystok : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Dabrowka Dopiewo : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Elblag : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
View More »
Gdansk : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Gdynia : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Gdynia : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Gliwice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Gliwice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Katowice : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Katowice : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Katowice : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Kraków : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Kraków : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Krakow : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Krakow : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lodz : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lodz : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Lublin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Myslowice : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Opole : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Poznan : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Poznan : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Poznan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Slupsk : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Swidnik : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Swidnik : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Szczecin : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
ToruÅ" : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Warsaw :
Twenty Four Month Extension Study of BA058-05-003
Warsaw : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Warszawa : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Warszawa : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Warszawa : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Wroclaw : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Wroclaw : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Puerto Rico
Rio Piedras : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Romania
Bucharest : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Bucharest : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Bucharest : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Bucharest :
Twenty Four Month Extension Study of BA058-05-003
Bucuresti : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
View More »
Iasi : Site Reference ID/Investigator# 53862
Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
Targu-Mures : Site Reference ID/Investigator# 53865
Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
Russian Federation
Arkhangelsk : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Ekaterinburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Ivanovo : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Ivanovo : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Moscow : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Moscow : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nizhniy Novgorod : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nizhny Novgorod : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Rostov-na-Dony : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Saint Petersburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Saint-Petersburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Yaroslavl : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Slovakia
Banska Bystrica : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Bratislava : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Bratislava : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Humenne : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Kosice : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
View More »
Kosice : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Kosice-Saca : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Lubochna : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Lucenec : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Martin : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Martin : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Nitra : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Nitra : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Presov : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Trnava : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Zilina : Research Site
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia® in Routine Clinical Practice
Slovenia
Celje : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Slovenj Gradec : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
South Africa
George : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Johannesburg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Kempton Park : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Paarl : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Parow : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
View More »
Port Elizabeth : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Pretoria : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Somerset West : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Tygerberg : Research Site Updated
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Tygerberg : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Spain
A Coruña : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Alcira : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Barcelona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Barcelona : Research Site Updated
An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Barcelona : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Barcelona : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Barcelona : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Barcelona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Cadiz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Girona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Granada : Research Site
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
Granada : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Leon : Hospital de Leon
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Madrid : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Madrid : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Madrid : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Madrid : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Marbella : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Pozuelo de Alarcón : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Sabadell : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Sant Joan DespÃ- : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Santander : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Sevilla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Sevilla : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Valencia : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Valencia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Sweden
Linköping : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Mölndal : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Malmo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Mölndal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Stockholm : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
View More »
Stockholm : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Umeå : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Switzerland
Bern : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Fribourg : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Geneva 14 : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Lausanne : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Zurich : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
United Kingdom
Birmingham : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Birmingham : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Birmingham : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cambridge : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Cardiff : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
View More »
Cardiff : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Chorley : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Chorley : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Edinburgh : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Glasgow : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Glasgow : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Liverpool : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Liverpool : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Manchester : Novartis Investigative Site
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Manchester : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Manchester : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Northwood : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Norwich : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Nottingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Reading : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Reading : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Sheffield : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Sidcup : Research Site
Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Staffordshire : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
Warwick : Research Site
Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis
